Volume 125, Issue 4, Pages (May 2006)

Slides:



Advertisements
Similar presentations
Volume 26, Issue 3, Pages (March 2007)
Advertisements

Volume 37, Issue 3, Pages (September 2012)
Volume 41, Issue 6, Pages (March 2011)
Volume 9, Issue 5, Pages (November 1998)
Volume 30, Issue 5, Pages (May 2009)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 55, Issue 1, Pages (July 2014)
Volume 26, Issue 3, Pages (March 2007)
Volume 31, Issue 2, Pages (August 2009)
Volume 26, Issue 1, Pages (January 2007)
Volume 36, Issue 1, Pages (January 2012)
Volume 47, Issue 5, Pages e6 (November 2017)
Volume 24, Issue 8, Pages (August 2018)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 24, Issue 3, Pages (March 2006)
Volume 42, Issue 4, Pages (April 2015)
Volume 7, Issue 2, Pages (February 2010)
Fyn Can Partially Substitute for Lck in T Lymphocyte Development
Volume 24, Issue 5, Pages (May 2006)
Direct Interactions of OCA-B and TFII-I Regulate Immunoglobulin Heavy-Chain Gene Transcription by Facilitating Enhancer-Promoter Communication  Xiaodi.
Volume 34, Issue 1, Pages (January 2011)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Manfred Kraus, Kaoru Saijo, Raul M Torres, Klaus Rajewsky  Immunity 
14-3-3σ Regulates Keratinocyte Proliferation and Differentiation by Modulating Yap1 Cellular Localization  Sumitha A.T. Sambandam, Ramesh B. Kasetti,
Volume 25, Issue 5, Pages (November 2006)
B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian.
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 25, Issue 5, Pages (November 2006)
Volume 25, Issue 2, Pages (August 2006)
Volume 28, Issue 4, Pages (April 2008)
Volume 6, Issue 1, Pages (January 1997)
Volume 41, Issue 4, Pages (October 2014)
Volume 28, Issue 4, Pages (April 2008)
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Volume 38, Issue 3, Pages (March 2013)
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
Volume 14, Issue 2, Pages (February 2001)
Volume 37, Issue 2, Pages (August 2012)
Volume 27, Issue 3, Pages (September 2007)
Stress-Induced Phosphorylation of S
TopBP1 Activates the ATR-ATRIP Complex
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Volume 28, Issue 3, Pages (March 2008)
Richard W. Deibler, Marc W. Kirschner  Molecular Cell 
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Volume 34, Issue 5, Pages (May 2011)
LAT Links the Pre-BCR to Calcium Signaling
Centrosome-Associated NDR Kinase Regulates Centrosome Duplication
Volume 13, Issue 10, Pages (December 2015)
Volume 125, Issue 4, Pages (May 2006)
Identification of Anergic B Cells within a Wild-Type Repertoire
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 39, Issue 3, Pages (August 2010)
Volume 28, Issue 5, Pages (May 2008)
Volume 33, Issue 1, Pages (July 2010)
Volume 10, Issue 4, Pages (April 1999)
In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets  Weiguo Zhai, Hyunkyung Jeong, Libin.
Volume 31, Issue 6, Pages (December 2009)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 26, Issue 3, Pages (March 2007)
Volume 46, Issue 2, Pages (April 2012)
Volume 31, Issue 5, Pages (November 2009)
Volume 55, Issue 1, Pages (July 2014)
Volume 28, Issue 1, Pages (January 2008)
Volume 23, Issue 2, Pages (August 2005)
Volume 65, Issue 5, Pages e4 (March 2017)
Volume 41, Issue 4, Pages (February 2011)
Volume 31, Issue 5, Pages (September 2008)
Volume 25, Issue 4, Pages (October 2006)
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

Volume 125, Issue 4, Pages 761-774 (May 2006) Nontranscriptional Regulation of SYK by the Coactivator OCA-B Is Required at Multiple Stages of B Cell Development  Rachael Siegel, Unkyu Kim, Alina Patke, Xin Yu, Xiaodi Ren, Alexander Tarakhovsky, Robert G. Roeder  Cell  Volume 125, Issue 4, Pages 761-774 (May 2006) DOI: 10.1016/j.cell.2006.03.036 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Oca-b−/− Mice Have an Altered Distribution of Bone-Marrow B Cells (A) Bone-marrow B cells from Oca-b+/+ mice were sorted based on surface expression of B220 and CD43. (B) Immunoblot for OCA-B using whole-cell extract from fractions sorted in (A). (C) Expression of OCA-B target genes examined by RT-PCR. Total bone-marrow cells were prepared prior to sorting. (A)–(C) are representative of four experiments. (D) Cellular populations from Oca-b+/+ and Oca-b−/− bone marrow were analyzed by flow cytometry using antibodies against the indicated cell surface markers. The numbers within the gates are percentages of live cells (low SSC). Data are representative of three experiments. (E) Size analysis of live cells (left) or B220+ cells (right) from bone marrow of Oca-b+/+ (solid) or Oca-b−/− (dashed) mice. Cell 2006 125, 761-774DOI: (10.1016/j.cell.2006.03.036) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 Expression Levels of Critical Genes for Pre-B Cell Signaling in Oca-b−/− Mice (A) Pre-B cells were sorted based on expression of CD19, CD43, and CD25. (B and C) qPCR was performed. The values shown are fold changes calculated by relative quantification using Gapdh to compare RNA levels in pre-B1 versus pre-B2 cells for each genotype using the equation ratio = (Etarget)ΔCT(Oca-b+/+preB1-Oca-b+/+preB2)/(EGAPDH)ΔCT(Oca-b+/+preB1-Oca-b+/+preB2). Genes that are induced in pre-B1 cells and pre-B2 cells are shown in (B) and (C), respectively. The values shown are averages generated from three to five independent experiments. Error bars represent standard deviations. (D) A similar method was used to determine the difference in expression of these genes between Oca-b+/+ and Oca-b−/− cells using the equation ratio = (Etarget)ΔCT(Oca-b+/+preB1-Oca-b−/−preB1)/(EGAPDH)ΔCT(Oca-b+/+preB1-Oca-b−/−preB1) for each cell stage. A negative value denotes that Oca-b−/− cells have fewer transcripts relative to wild-type cells. The values shown are averages generated from three to five independent experiments. ND, not determined. Cell 2006 125, 761-774DOI: (10.1016/j.cell.2006.03.036) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Altered Response of Oca-b−/− B Cells to IL-7 (A) Whole-cell extracts from Oca-b+/+ CD19+ cells cultured with IL-7 were prepared at the indicated time points. The CD19+ extract was prepared after sorting but prior to IL-7 culture. After IL-7 removal, the culture was continued for 52 hr. OCA-B expression was monitored by immunoblot. (B) CD19+ cells were isolated from bone marrow of Syk+/+, Syk−/−, Oca-b+/+, or Oca-b−/− mice and cultured with media containing IL-7 for up to 7 days. Live cells were counted using trypan blue exclusion to measure proliferation during the time course. Each point represents the average fold increase for three mice. Error bars represent standard deviations. (C) Surface expression of the pre-BCR during the time course was analyzed by flow cytometry; the 48 hr time point of IL-7 exposure is shown. The values shown are percentages of live cells within the pre-BCR+/CD43+ gate and are averages of three representative experiments. (D) CD19+ cells were isolated from bone marrow of Oca-b+/+ or Oca-b−/− mice and cultured with media containing IL-7 for up to 142 hr. After IL-7 removal, the culture was continued for 52 hr. Igκ+ cells were monitored in three independent experiments, and the percentages of cells within the gates shown were averaged to generate the values shown. Cell 2006 125, 761-774DOI: (10.1016/j.cell.2006.03.036) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 Analysis of Pre-BCR Function and SYK Expression in Oca-b−/− Cells (A) Bone-marrow CD19+ cells were isolated and cultured in IL-7 for 48 hr. After depletion of κ+ cells, the pre-BCR was crosslinked for various lengths of time. Tyrosine phosphorylation in the cellular extract was monitored (pTYR). The band corresponding to phospho-SYK is labeled. The total protein levels of SYK, LCK, ERK, FYN, OCA-B, and actin were also examined. The data are a representative set from four experiments. (B) qPCR was used to analyze SYK RNA levels in the cells that were used for the experiment in (A). Relative quantification was used to compare the genotypes, and a negative value denotes fewer transcripts in Oca-b−/− cells. The values shown are averages generated from three experiments. Error bars represent standard deviations. (C) Pre-B cells were sorted based on expression of CD19, CD43, and CD25. Immunoblotting was performed for SYK, LCK, actin, and ERK. The data are representative of two experiments. (D–F) Total B cells were isolated from the spleens of Oca-b+/+ or Oca-b−/− mice. The cells were activated in culture with anti-IgM (D); anti-IgM, anti-CD40, and IL-4 (E); or LPS (F) for up to 120 hr. Expression of SYK, phosphorylated SYK at tyrosine 317 (SYKpY317), and ERK were analyzed by immunoblot. The activation experiments were performed three times. (G) Resting B cells were isolated from spleens of Oca-b+/+ or Oca-b−/− mice and activated with anti-IgM for up to 24 hr in either the presence (+CHX) or absence (−CHX) of cycloheximide. The stabilities of SYK and ERK were monitored by immunoblot. Cell 2006 125, 761-774DOI: (10.1016/j.cell.2006.03.036) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 5 Analysis of Subcellular Localization of IgM, SYK, and OCA-B by Immunofluorescence Microscopy (A) Namalwa cells were stimulated with anti-IgM for 120 min (t = 120) or left unstimulated (t = 0), after which the localizations of IgM (red), OCA-B (green), and SYK (green) were analyzed. To show colocalization, the red and green channels were merged (merge). DAPI was used for nuclear staining. The data are representative of three experiments. (B) Namalwa cells were stimulated with anti-IgM, anti-CD40, and IL-4 for up to 120 min or left unstimulated (t = 0) and imaged as in (A). t = 10 min is shown. (C and D) The occurrence of cells with cytoplasmic staining of OCA-B (as visualized by immunofluorescence microscopy) during a time course of stimulation is presented. For each time point, 600 cells were scored for the presence of either nuclear and cytoplasmic (C) or mainly cytoplasmic (D) staining for OCA-B. Anti-IgM stimulation is shown in blue; anti-IgM, anti-CD40, and IL-4 costimulation is shown in red. Counting was performed for three independent experiments. The error bars are standard deviations based on averaging the number of cells counted. Cell 2006 125, 761-774DOI: (10.1016/j.cell.2006.03.036) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 6 Analysis and Characterization of the OCA-B-SYK Interaction (A) Oca-b+/+ splenic B cells were activated in culture with anti-IgM for a time course from t = 0 to 5 hr. Immunoprecipitation (IP) was performed using anti-OCA-B or IgG (control) and whole-cell extract (WCE). The presence of SYK in the IP was monitored by immunoblotting. The total level of SYK, ERK, and tyrosine-phosphorylated proteins (pTYR) in the WCE was also examined. (B) Oca-b+/+ splenic B cells were activated in culture with anti-IgM, anti-CD40, and IL-4. IP of OCA-B or SYK from WCE was detected by immunoblot. The total protein level is shown for OCA-B and ERK (bottom panels). Each IP experiment was reproduced at least four times. (C) Coomassie blue-stained SDS gel showing purified GST or GST-OCA-B proteins (products marked by arrows). (D) Purified His-tagged SYK was incubated with immobilized GST or GST-OCA-B proteins, and bound SYK was monitored by immunoblotting. This experiment was performed at least three times. (E) Purified His-tagged SYK or Ni-NTA beads alone (control) were incubated with Namalwa cellular extracts. The binding of OCA-B was monitored by immunoblotting. Long and short exposures are shown to distinguish OCA-B p34 and p35. This experiment was reproduced five times. (F) WCE from Namalwa cells that were stimulated with anti-IgM for a time course was used for IP with anti-OCA-B. The presence of SYK and tyrosine-phosphorylated proteins (pTYR) in the WCE and IP were analyzed by immunoblot, and the band that corresponds to phosphorylated SYK is labeled. This experiment was performed twice. (G) Purified His-tagged SYK proteins were incubated with S100 from Namalwa cells. The binding of OCA-B was monitored by immunoblotting. SH2-L = SH2 domains and linker domain, SH2 = SH2 domains alone, L = linker domain, LK = linker domain and kinase domain, and LKΔ = truncations of the linker-kinase construct. This experiment was performed twice. Cell 2006 125, 761-774DOI: (10.1016/j.cell.2006.03.036) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 7 Rescue of Oca-b−/− Mice with OCA-B Transgenes (A) CD19+ B cells were isolated from bone marrow of Oca-b+/+ (Oca-b−/− with wild-type Oca-b transgene), p34+/+ (Oca-b−/− with p34-Oca-b transgene), p35+/+ (Oca-b−/− with p35-Oca-b transgene), or Oca-b−/− (no transgene) mice, and the experiment was carried out as in Figure 2A. (B) WCE was prepared from CD19+ bone-marrow B cells that had been cultured in IL-7 for 48 hr. The restoration of SYK protein stability in transgenic mice was monitored by immunoblot. This experiment was performed twice. Cell 2006 125, 761-774DOI: (10.1016/j.cell.2006.03.036) Copyright © 2006 Elsevier Inc. Terms and Conditions